Jordheim L - Search Results

1

Sensitization of ara-C-resistant lymphoma cells by a pronucleotide analogue.

Galmarini CM, Clarke ML, Santos CL, Jordheim L, Perigaud C, Gosselin G, Cros E, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: jordheim l. Int J Cancer. 2003 Oct 20;107(1):149-54. doi: 10.1002/ijc.11339. Int J Cancer. 2003. PMID: 12925971

2

[Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues].

Jordheim LP, Galmarini CM, Dumontet C. Jordheim LP, et al. Bull Cancer. 2005 Mar;92(3):239-48. Bull Cancer. 2005. PMID: 15820918 Free article. Review. French.

3

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene.

Galmarini CM, Clarke ML, Jordheim L, Santos CL, Cros E, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: jordheim l. BMC Pharmacol. 2004 May 24;4:8. doi: 10.1186/1471-2210-4-8. BMC Pharmacol. 2004. PMID: 15157282 Free PMC article.

4

Problems related to resistance to cytarabine in acute myeloid leukemia.

Cros E, Jordheim L, Dumontet C, Galmarini CM. Cros E, et al. Among authors: jordheim l. Leuk Lymphoma. 2004 Jun;45(6):1123-32. doi: 10.1080/1042819032000159861. Leuk Lymphoma. 2004. PMID: 15359991 Review.

5

F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation.

Jordheim LP, Cros E, Galmarini CM, Dumontet C, Bretonnet AS, Krimm I, Lancelin JM, Gagnieu MC. Jordheim LP, et al. Nucleosides Nucleotides Nucleic Acids. 2006 Mar;25(3):289-97. doi: 10.1080/15257770500458027. Nucleosides Nucleotides Nucleic Acids. 2006. PMID: 16629121

6

Recent developments to improve the efficacy of cytotoxic nucleoside analogues.

Jordheim LP, Galmarini CM, Dumontet C. Jordheim LP, et al. Recent Pat Anticancer Drug Discov. 2006 Jun;1(2):163-70. doi: 10.2174/157489206777442205. Recent Pat Anticancer Drug Discov. 2006. PMID: 18221034 Review.

7

Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine.

Galmarini CM, Voorzanger N, Falette N, Jordheim L, Cros E, Puisieux A, Dumontet C. Galmarini CM, et al. Among authors: jordheim l. Biochem Pharmacol. 2003 Jan 1;65(1):121-9. doi: 10.1016/s0006-2952(02)01448-x. Biochem Pharmacol. 2003. PMID: 12473386

8

Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.

Galmarini CM, Thomas X, Graham K, El Jafaari A, Cros E, Jordheim L, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: jordheim l. Br J Haematol. 2003 Jul;122(1):53-60. doi: 10.1046/j.1365-2141.2003.04386.x. Br J Haematol. 2003. PMID: 12823345 Free article.

9

Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.

Galmarini CM, Jordheim L, Dumontet C. Galmarini CM, et al. Among authors: jordheim l. Leuk Lymphoma. 2003 Jul;44(7):1105-11. doi: 10.1080/1042819031000077142. Leuk Lymphoma. 2003. PMID: 12916861 Review.

10

Pyrimidine nucleoside analogs in cancer treatment.

Galmarini CM, Jordheim L, Dumontet C. Galmarini CM, et al. Among authors: jordheim l. Expert Rev Anticancer Ther. 2003 Oct;3(5):717-28. doi: 10.1586/14737140.3.5.717. Expert Rev Anticancer Ther. 2003. PMID: 14599094 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters